CholelithiasisPhase 1NCT00815438
Transvaginal Cholecystectomy Using Endoscopic Assistance
A Phase 1 study testing cholecystectomy. in people with Cholelithiasis and Cholecystitis, run by University of Missouri-Columbia.
Trial summary
Surgical removal of the gallbladder is needed in 1 million people per year in the USA. The procedure is done by placing four tubes (cannula) from 5 to 10 mm through the abdominal wall. Air is placed in the abdominal cavity and a lighted scope is placed through one cannula. Read more about this study
- Who is it for?
- Ages 18 to 80 years, women only
- Conditions the study is for
- Cholelithiasis, Cholecystitis, Biliary Dyskinesia
- What is being tested?
- cholecystectomy.
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- Jan 2009to May 2011
- Phase
- Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Female age ≥ 18 yrs
- Diagnosis of cholelithiasis, cholecystectomy, choledocholithiasis or biliary dyskinesia and scheduled for laparoscopic cholecystectomy
- Have an indication for a standard laparoscopic procedure cholecystectomy
- Not pregnant
Who cannot join
- Any significant co-morbidities, including significant cardiac disease, history of stroke, severe pulmonary disease, hypertension with a diastolic greater than 100, pancreatitis.
- Patients that are immunosuppressed or on immunosuppression therapy.
- An unacceptable psychological or medical risk as determined by the primary investigators.
About this study
Official title: Laparoscopic Cholecystectomy Using Transvaginal Endoscopic Assistance
Surgical removal of the gallbladder is needed in 1 million people per year in the USA. The procedure is done by placing four tubes (cannula) from 5 to 10 mm through the abdominal wall. Air is placed in the abdominal cavity and a lighted scope is placed through one cannula. The space in the abdominal cavity can then be seen on a video screen. Thin retractors and dissecting instruments are placed through the other cannula and the gallbladder is removed using the video screen for vision. The gallbladder duct and the artery are usually occluded with clips or stitches.
In this study we propose to do the procedure though a single 5 mm incision placed at the umbilicus and a second access through the vagina using a flexible endoscope. The gallbladder will be retracted using strings (sutures) attached to the gallbladder. The dissection will be done using laparoscopic instruments (scissors, knives, dissectors) placed through the laparoscopic port. A flexible grasper may be used in the endoscope to help with retraction. An endoscopic snare or grasper will be used to grasp the gallbladder and remove it from the abdomen through the vagina.
This study evaluates the ability to do laparoscopic cholecystectomy with one skin incision and one vaginal incision. This will provide the basis for future studies evaluating decreased pain and costs with transvaginal assisted cholecystectomy.
Read the detailed description
BACKGROUND When doing laparoscopic cholecystectomy, there are generally four ports placed through four separate skin incisions. One port is used for a rigid laparoscope, two for retraction, and one for dissecting. We have recently started to reduce the number of incisions for laparoscopic cholecystectomy to one umbilical incision. Three ports are used through one incision by suspending the gallbladder to the abdominal wall using sutures. This allows the surgeon to eliminate incisions and the patients have reduced postoperative wound pain and improved cosmesis. However, by using standard laparoscopic rigid instruments and optic systems it is challenging to perform this operation via a single incision.
Recently, natural orifice transluminal endoscopic surgery (NOTES) has been used in females to reduce the size and number of fascial incisions of the anterior abdominal wall. This vaginal approach has generally been done with the aid of laparoscopy (hybrid procedure). The vaginal assistance may allow small abdominal wall incisions resulting in less pain and faster recovery than after the standard laparoscopic approach.
We propose a phase I study of a laparoscopic cholecystectomy using a single 5 mm port and transvaginal endoscopic assistance in 10 female patients. The procedure will have at least one 5 mm laparoscopic port for safety and assistance. Conversions to conventional laparoscopic surgery will be done if difficulties are encountered.
OBJECTIVE Reduction in the number of ports required in laparoscopic cholecystectomy.
Null hypothesis: Laparoscopic cholecystectomy requires two or more fascial port sites to perform.
Alternative hypothesis: Laparoscopic cholecystectomy can be done with a single 5 mm laparoscopic port with transvaginal assistance of flexible endoscopy.
The standard laparoscopic procedure will be used as the control.
STUDY DESIGN This study will be conducted as a prospective, single site, non-randomized, single-arm study among elective surgery patients. Subjects will be enrolled from a population of otherwise healthy females undergoing laparoscopic surgery for cholelithiasis, cholecystitis, or biliary dyskinesia. Patients enrolled in the study will have a flexible transvaginal endoscopy used during laparoscopic cholecystectomy. Subjects enrolled will be told that the primary purpose of the study is to try to reduce the number of laparoscopic ports and skin incisions that are necessary to perform their cholecystectomy. Subjects will be followed for approximately 6 weeks post treatment for purposes of the study.
STUDY PROCEDURE At surgery, the patient will be placed in the dorsal lithotomy position. Sterile prep and drape of the anterior abdominal wall, perineum, and vagina will be obtained.. A 7-8 mm umbilical skin incision will be made. Using standard techniques, a Veress insufflation needle will be placed at the umbilicus to establish pneumoperitoneum. A 5 mm laparoscopic port will then be placed at the umbilicus. Pressure will be set from 6 to 15 mm of mercury to obtain an adequate working space.
Patients will then undergo a pelvic exam by a gynecologist followed by placement of a weighted speculum into the vagina. Forceps or tenaculum will then be used to grasp the posterior lip of the cervix and the cervico-vaginal junction identified. A uterine manipulator will be placed into the uterus to allow manipulation of the uterus. A 10 mm incision will be made though the posterior vaginal wall 1 cm from the cervix. The patient will then be placed into deep Trendelenburg positioning. A 10mm trocar will be placed against the posterior vaginal fornix creating a point of pressure on the pelvic peritoneum visible by laparoscopy. This point will be in the midline of posterior fornix between the utero-sacral ligaments. The weighted speculum will be removed and gently steady pressure will be applied to the vaginal trocar until entry into the posterior cul-de-sac is directly visualized by the laparoscope. Alternatively, the colpotomy will be performed without using a trocar, under direct vision. One of two Olympus flexible scopes will be used. An 8.7 mm sterile Olympus flexible single channel gastroscope can be placed though the vaginal port. A 2 channel scope requires removal ofthe10 mm vaginal port and placement of the 2 channel scope over a wire. All scope insertions will be observed under laparoscopy for safety.
The gallbladder will then have 1-4 sutures or endoloops attached to the gallbladder and placed through the anterior abdominal wall using a 1 mm suture passer (GraNee). Dissection will be done around the cystic duct using commercially available laparoscopic dissectors. For dissection of the gallbladder and cystic duct/artery, the flexible instruments will be used via the endoscope as alternative to laparoscopic instruments where appropriate. The cystic duct will be clipped with laparoscopic clips and divided. The cystic artery will be dissected clipped and divided in a similar fashion. The gallbladder will then be dissected from the gallbladder bed.
If indicated by the surgeon to facilitate or complete the procedure, laparoscopic ports will be added through additional abdominal wall incision sites. Laparoscopic instruments will assist in the procedure as needed by the judgment of the surgeon. The addition of laparoscopic ports and/or instruments will be documented. Rarely the gallbladder cannot be removed in a laparoscopic fashion and must be removed in an open manner. This same risk is present for any laparoscopic cholecystectomy.
Once the gallbladder is detached, the traction sutures will be cut. An endoscopic snare or grasper will be used to grasp the gallbladder and remove it from the abdomen through the vagina. Should an endocatch bag be needed to extract the gallbladder, it will be placed via the vaginal port and visualized by laparoscopy. The gallbladder bed will be inspected and irrigated. The skin is closed in a subcuticular manner. The laparoscopic fascial port will not be closed which is standard for 5 mm ports. The posterior vagina will be closed with a running absorbable suture. The pelvic peritoneum will not be closed which is standard in many pelvic operations. Post operative care with be identical to laparoscopic cholecystectomy.
- Conditions
- Cholelithiasis, Cholecystitis, Biliary Dyskinesia
- Being tested
- cholecystectomy.
- Keywords
- Transvaginal, Cholecystectomy, NOTES, Endoscopic
- Medical subject headings
- Cholelithiasis, Cholecystitis, Biliary Dyskinesia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
cholecystectomy.Procedure or surgery
Also called Gallbladder removal
Patients enrolled in the study will have a flexible transvaginal endoscopy used during laparoscopic cholecystectomy.
| Study group | Role | What they receive |
|---|---|---|
| Surgical Procedure | Experimental | Laparoscopic transvaginal cholecystectomy with endoscopic assistance. Receives: Procedure: cholecystectomy. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reduction in the number of laparoscopic ports
Measured: Time of surgery
Secondary outcomes (3)
Cost analysis comparison of surgical procedures.
Measured: Cost analysis will be done at end of study.
Time of procedure
Measured: Time recorded during surgical procedure.
Cosmesis and pain
Measured: Prior to procedure, 1 to 3 days post op, 7 to 10 days post op, and at follow-up visit ~6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Dec 2008 (estimated)
- Study startJan 2009
- Primary completionMay 2011
- Study completionMay 2011
Why it stopped: Study personnel left institution
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CholelithiasisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Missouri-Columbia
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Brent Miedema, MD, Principal investigator, University of Missouri-Columbia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00815438
- Sponsor's protocol ID
- 1125518
- Status last verified
- Sep 2016
- First submitted
- 29 Dec 2008
- Last updated
- 30 Sep 2016
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Sep 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Laparoscopic Cholecystectomy Using Transvaginal Endoscopic Assistance
- ClinicalTrials.gov ID
- NCT00815438
- Acronym / sponsor ID
- 1125518
- Conditions
- Cholelithiasis, Cholecystitis, Biliary Dyskinesia
- Keywords
- Transvaginal, Cholecystectomy, NOTES, Endoscopic
- Phase
- Phase 1
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Study personnel left institution
- Enrolment
- 0 participants (actual)
- Lead sponsor
- University of Missouri-ColumbiaUniversity, hospital or other
- Study start
- Jan 2009
- Primary completion
- May 2011 (actual)
- Study completion
- May 2011 (actual)
- First posted
- 30 Dec 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Surgical removal of the gallbladder is needed in 1 million people per year in the USA. The procedure is done by placing four tubes (cannula) from 5 to 10 mm through the abdominal wall. Air is placed in the abdominal cavity and a lighted scope is placed through one cannula. The space in the abdominal cavity can then be seen on a video screen. Thin retractors and dissecting instruments are placed through the other cannula and the gallbladder is removed using the video screen for vision. The gallbladder duct and the artery are usually occluded with clips or stitches.
In this study we propose to do the procedure though a single 5 mm incision placed at the umbilicus and a second access through the vagina using a flexible endoscope. The gallbladder will be retracted using strings (sutures) attached to the gallbladder. The dissection will be done using laparoscopic instruments (scissors, knives, dissectors) placed through the laparoscopic port. A flexible grasper may be used in the endoscope to help with retraction. An endoscopic snare or grasper will be used to grasp the gallbladder and remove it from the abdomen through the vagina.
This study evaluates the ability to do laparoscopic cholecystectomy with one skin incision and one vaginal incision. This will provide the basis for future studies evaluating decreased pain and costs with transvaginal assisted cholecystectomy.
Detailed description
BACKGROUND When doing laparoscopic cholecystectomy, there are generally four ports placed through four separate skin incisions. One port is used for a rigid laparoscope, two for retraction, and one for dissecting. We have recently started to reduce the number of incisions for laparoscopic cholecystectomy to one umbilical incision. Three ports are used through one incision by suspending the gallbladder to the abdominal wall using sutures. This allows the surgeon to eliminate incisions and the patients have reduced postoperative wound pain and improved cosmesis. However, by using standard laparoscopic rigid instruments and optic systems it is challenging to perform this operation via a single incision.
Recently, natural orifice transluminal endoscopic surgery (NOTES) has been used in females to reduce the size and number of fascial incisions of the anterior abdominal wall. This vaginal approach has generally been done with the aid of laparoscopy (hybrid procedure). The vaginal assistance may allow small abdominal wall incisions resulting in less pain and faster recovery than after the standard laparoscopic approach.
We propose a phase I study of a laparoscopic cholecystectomy using a single 5 mm port and transvaginal endoscopic assistance in 10 female patients. The procedure will have at least one 5 mm laparoscopic port for safety and assistance. Conversions to conventional laparoscopic surgery will be done if difficulties are encountered.
OBJECTIVE Reduction in the number of ports required in laparoscopic cholecystectomy.
Null hypothesis: Laparoscopic cholecystectomy requires two or more fascial port sites to perform.
Alternative hypothesis: Laparoscopic cholecystectomy can be done with a single 5 mm laparoscopic port with transvaginal assistance of flexible endoscopy.
The standard laparoscopic procedure will be used as the control.
STUDY DESIGN This study will be conducted as a prospective, single site, non-randomized, single-arm study among elective surgery patients. Subjects will be enrolled from a population of otherwise healthy females undergoing laparoscopic surgery for cholelithiasis, cholecystitis, or biliary dyskinesia. Patients enrolled in the study will have a flexible transvaginal endoscopy used during laparoscopic cholecystectomy. Subjects enrolled will be told that the primary purpose of the study is to try to reduce the number of laparoscopic ports and skin incisions that are necessary to perform their cholecystectomy. Subjects will be followed for approximately 6 weeks post treatment for purposes of the study.
STUDY PROCEDURE At surgery, the patient will be placed in the dorsal lithotomy position. Sterile prep and drape of the anterior abdominal wall, perineum, and vagina will be obtained.. A 7-8 mm umbilical skin incision will be made. Using standard techniques, a Veress insufflation needle will be placed at the umbilicus to establish pneumoperitoneum. A 5 mm laparoscopic port will then be placed at the umbilicus. Pressure will be set from 6 to 15 mm of mercury to obtain an adequate working space.
Patients will then undergo a pelvic exam by a gynecologist followed by placement of a weighted speculum into the vagina. Forceps or tenaculum will then be used to grasp the posterior lip of the cervix and the cervico-vaginal junction identified. A uterine manipulator will be placed into the uterus to allow manipulation of the uterus. A 10 mm incision will be made though the posterior vaginal wall 1 cm from the cervix. The patient will then be placed into deep Trendelenburg positioning. A 10mm trocar will be placed against the posterior vaginal fornix creating a point of pressure on the pelvic peritoneum visible by laparoscopy. This point will be in the midline of posterior fornix between the utero-sacral ligaments. The weighted speculum will be removed and gently steady pressure will be applied to the vaginal trocar until entry into the posterior cul-de-sac is directly visualized by the laparoscope. Alternatively, the colpotomy will be performed without using a trocar, under direct vision. One of two Olympus flexible scopes will be used. An 8.7 mm sterile Olympus flexible single channel gastroscope can be placed though the vaginal port. A 2 channel scope requires removal ofthe10 mm vaginal port and placement of the 2 channel scope over a wire. All scope insertions will be observed under laparoscopy for safety.
The gallbladder will then have 1-4 sutures or endoloops attached to the gallbladder and placed through the anterior abdominal wall using a 1 mm suture passer (GraNee). Dissection will be done around the cystic duct using commercially available laparoscopic dissectors. For dissection of the gallbladder and cystic duct/artery, the flexible instruments will be used via the endoscope as alternative to laparoscopic instruments where appropriate. The cystic duct will be clipped with laparoscopic clips and divided. The cystic artery will be dissected clipped and divided in a similar fashion. The gallbladder will then be dissected from the gallbladder bed.
If indicated by the surgeon to facilitate or complete the procedure, laparoscopic ports will be added through additional abdominal wall incision sites. Laparoscopic instruments will assist in the procedure as needed by the judgment of the surgeon. The addition of laparoscopic ports and/or instruments will be documented. Rarely the gallbladder cannot be removed in a laparoscopic fashion and must be removed in an open manner. This same risk is present for any laparoscopic cholecystectomy.
Once the gallbladder is detached, the traction sutures will be cut. An endoscopic snare or grasper will be used to grasp the gallbladder and remove it from the abdomen through the vagina. Should an endocatch bag be needed to extract the gallbladder, it will be placed via the vaginal port and visualized by laparoscopy. The gallbladder bed will be inspected and irrigated. The skin is closed in a subcuticular manner. The laparoscopic fascial port will not be closed which is standard for 5 mm ports. The posterior vagina will be closed with a running absorbable suture. The pelvic peritoneum will not be closed which is standard in many pelvic operations. Post operative care with be identical to laparoscopic cholecystectomy.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Surgical Procedure | Experimental | Procedure: cholecystectomy.Laparoscopic transvaginal cholecystectomy with endoscopic assistance. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Female age ≥ 18 yrs
- Diagnosis of cholelithiasis, cholecystectomy, choledocholithiasis or biliary dyskinesia and scheduled for laparoscopic cholecystectomy
- Have an indication for a standard laparoscopic procedure cholecystectomy
- Not pregnant
Key exclusion criteria (3 listed)
- Any significant co-morbidities, including significant cardiac disease, history of stroke, severe pulmonary disease, hypertension with a diastolic greater than 100, pancreatitis.
- Patients that are immunosuppressed or on immunosuppression therapy.
- An unacceptable psychological or medical risk as determined by the primary investigators.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| cholecystectomy.Also: Gallbladder removalPatients enrolled in the study will have a flexible transvaginal endoscopy used during laparoscopic cholecystectomy. | Procedure or surgery | Surgical Procedure |
Primary outcome
Reduction in the number of laparoscopic ports
Time frame: Time of surgery
3 secondary outcomes
Cost analysis comparison of surgical procedures.
Time frame: Cost analysis will be done at end of study.
Time of procedure
Time frame: Time recorded during surgical procedure.
Cosmesis and pain
Time frame: Prior to procedure, 1 to 3 days post op, 7 to 10 days post op, and at follow-up visit ~6 weeks
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Sep 2016.
- Individual participant dataSharing planned: No
Related trials for Cholelithiasis
Recruiting
Timing of CHolecystectomy In Severe PAncreatitis
Acute Pancreatitis, Cholelithiasis
RecruitingObservational study
Electrosurgical Patterns and Learning Curve in Elective Laparoscopic Cholecystectomy
Cholelithiasis
RecruitingPhase 4
Time to Loss of Consciousness With Remimazolam Versus Propofol for Anesthetic Induction in Laparoscopic Cholecystectomy
Intravenous Anesthesia, Cholelithiasis
Recruiting
Ultrasound-Guided Rectus Sheath Block Versus Local Infiltration
Cholelithiases, Cholecystitis
Active, not recruitingPhase 4
A Randomized Controlled Trial Comparing the Effects of Different Anesthetic Sedatives on PONV in Laparoscopic Cholecystectomy
Cholelithiasis, Postoperative Nausea and Vomiting
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Brent Miedema, MD principal investigator
University of Missouri-Columbia
Questions about this trial
What is this clinical trial studying?
A Phase 1 study testing cholecystectomy. in people with Cholelithiasis and Cholecystitis, run by University of Missouri-Columbia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 30 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reduction in the number of laparoscopic ports (time frame: Time of surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2016.